Atlas Private Wealth Advisors Has $849,000 Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Atlas Private Wealth Advisors trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 2.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,680 shares of the healthcare conglomerate’s stock after selling 45 shares during the quarter. Atlas Private Wealth Advisors’ holdings in UnitedHealth Group were worth $849,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also added to or reduced their stakes in UNH. Eclectic Associates Inc. ADV grew its position in shares of UnitedHealth Group by 3.4% during the 4th quarter. Eclectic Associates Inc. ADV now owns 9,798 shares of the healthcare conglomerate’s stock worth $4,956,000 after buying an additional 320 shares during the period. Goelzer Investment Management Inc. increased its stake in UnitedHealth Group by 10.2% in the fourth quarter. Goelzer Investment Management Inc. now owns 16,532 shares of the healthcare conglomerate’s stock valued at $8,363,000 after purchasing an additional 1,535 shares in the last quarter. Gradient Investments LLC boosted its position in shares of UnitedHealth Group by 1.3% during the 4th quarter. Gradient Investments LLC now owns 97,007 shares of the healthcare conglomerate’s stock worth $49,072,000 after purchasing an additional 1,288 shares in the last quarter. CX Institutional increased its position in UnitedHealth Group by 1.0% in the 4th quarter. CX Institutional now owns 10,853 shares of the healthcare conglomerate’s stock valued at $5,490,000 after buying an additional 103 shares in the last quarter. Finally, Berbice Capital Management LLC bought a new position in UnitedHealth Group in the fourth quarter worth approximately $3,542,000. 87.86% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts recently issued reports on UNH shares. TD Cowen increased their target price on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Morgan Stanley decreased their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Royal Bank of Canada cut their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. Oppenheimer raised their target price on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Finally, KeyCorp reissued an “overweight” rating and issued a $650.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of $627.74.

UnitedHealth Group Stock Up 0.5 %

Shares of NYSE UNH opened at $532.26 on Friday. The business’s fifty day moving average price is $542.24 and its 200-day moving average price is $563.54. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The stock has a market capitalization of $489.83 billion, a PE ratio of 34.34, a P/E/G ratio of 1.41 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company’s revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the company earned $5.83 earnings per share. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.74 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.58%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s payout ratio is 54.19%.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at this link. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.